Highlights Bastide Le Confort Médical London S.E.

Equities

Delayed London S.E. Other stock markets 11:30:39 2024-04-16 EDT			5-day change	1st Jan Change
15.62 ^EUR	-54.92%		-17.17%	-41.49%

05-15	BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction
05-15	Bastide: 8.2% increase in quarterly sales	CF

BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction	05-15
Bastide: 8.2% increase in quarterly sales	05-15	CF
BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%)	04-09
Bastide: new contract with the British NHS	04-09	CF
BASTIDE LE CONFORT MEDICAL : The prioritised debt reduction awaits further visible progress	03-21
Bastide Le Confort Médical SA Reports Earnings Results for the Half Year Ended December 31, 2023	03-20	CI
BASTIDE LE CONFORT MEDICAL : Reiterated guidance and further progress on the in debt profile	02-15
Bastide: half-year sales up 5.7% organically	02-15	CF
Bastide Le Confort Offloads Majority Owned Medical Devices Seller Distrimed	12-05	MT
Bastide: sells its Distrimed subsidiary to the Hygie31 group	12-04	CF
Hygie31 acquired 70% stake in Distrimed SAS from Bastide Le Confort Médical SA.	12-03	CI
Bastide Le Confort Médical SA Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-31	CI
Bastide: publishes record EBITDA for 2022/2023	23-10-18	CF
Bastide: 10.9% rise in annual sales	23-08-30	CF
Groupe Bastide Makes Acquisitions in France, Netherlands	23-07-07	MT
Bastide Le Confort MÃ©dical SA acquired Oxigo B.V.	23-07-05	CI
Bastide Le Confort MÃ©dical SA acquired Occit'perf.	23-07-05	CI
Bastide: 42% increase in first-half net income	23-03-23	CF
Bastide Le Confort Médical Sa Provides Earnings Guidance for the Year 2023	23-03-22	CI
Bastide Le Confort Médical SA Reports Earnings Results for the Half Year Ended December 31, 2022	23-03-22	CI

No results for this search

BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction

May 15, 2024 at 02:40 pm